Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer

This publication has 28 references indexed in Scilit:

• High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin’s disease is unlikely to be associated with a major increased risk of secondary MDS/AML
  British Journal of Cancer, 1999
• Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT
  British Journal of Haematology, 1999
• Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1999
• Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow
  Leukemia, 1997
• Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma
  American Journal of Hematology, 1997
• Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1994
• Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer
  New England Journal of Medicine, 1992
• Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy
  Cancer, 1989
• Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
  Journal of Clinical Oncology, 1986
• Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.
  Journal of Clinical Oncology, 1985